Marvel Discovery Corp announced it had closed the first tranche a non-brokered private placement for aggregate gross proceeds of $908,080. Funds from the private placement will go towards development of the resource company's property portfolio, which includes projects across Canada. The Vancouver-based company issued 5,385,385 flow-through units at a price of $0.13 per unit. Each unit consisting of one flow-through share and one-half of one warrant exercisable at a price of $0.25 for a period of 24 months following the acceptance date.
Bluerush Inc said it has been selected by Quadient, a leader in helping businesses create meaningful customer connections through digital and physical channels, as its global technology partner. "We are honoured to be chosen as Quadient's first-ever global technology partner," said Steve Taylor, chief executive officer of Bluerush in a statement. "We look forward to continuing our collaboration with it to offer best-in-class technology and expand its customer experience management (CXM) software solutions." Bluerush was awarded the Global Technology of the Year Award at the recent Quadient Experience Partner Awards of its Inspire Days event. The company noted that it has worked with Quadient in its journey to bring customers the power of interactive personalized video for customer communications management.
Champion Gaming (TSX-V:WAGR) Group Inc. co-founder and CEO Ken Hershman and his team joined George Khalife, vice president of Capital Formation US, at the TMX Group (TSX:X), to celebrate the company's new listing on the TSX Venture Exchange and open the market. Champion Gaming (TSX-V:WAGR) is a sports content, data, and analytics company that provides predictive and prescriptive analytical models and win probability applications and statistics in the sports industry for teams, media, fans, and bettors. The sports analytical and data solutions currently offered by Champion to its customers include a fully customized probability engine; interactive sports matchup models; spread and over/under distributions; and sports statistics and historical data statistics.
Vuzix Corporation (NASDAQ:VUZI) has signed a distribution agreement with Barcotec GmbH, a European supplier of innovative hardware device management cloud services to companies and institutions. In a statement, Vuzix said it has received and shipped against an initial order from Barcotec for its Vuzix Smart Glasses. Founded in 1989, Barcotec helps companies gain a competitive advantage through the use of technological tools for the design of digital work processes in production, logistics, trade, field service, and healthcare.
Psyence Group Inc (CSE:PSYG), a life science biotechnology company pioneering the use of natural psychedelics aimed at mental health and well-being, revealed that the company’s CEO Neil Maresky, will be presenting at the virtual HC Wainwright 2nd Annual Psychedelics Conference on December 6th, 2021. The company’s key divisions, Psyence Production, Psyence Therapeutics, and Psyence Function, anchor an international collaboration, with operations in Canada, the United Kingdom, Jamaica, South Africa, and a presence in the United States and Australia. To register for the event visit https://hcwevents.com/psychedelics. To schedule a one-on-one meeting with the Psyence management, investors should email lk@hcwco.com, or ir@psyence.com.
Context Therapeutics (NASDAQ:CNTX) Inc, a women’s oncology company, has said it is in a pivotal period following its debut on the Nasdaq and a recent private placement of its units that extends its cash runway into 2024. Releasing third-quarter results, the company told investors it also strengthened its leadership team with the addition of chief financial officer Jennifer Minai-Azary and chief legal officer Alex Levit, who was instrumental in getting Context listed. “Additionally, the clinical evaluation of our lead product candidate Onapristone extended-release (ONA-XR) continues to progress, with three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian and endometrial cancers currently enrolling patients,” Context CEO Martin Lehr said in a statement.
American Manganese Inc, the company which upcycles lithium-ion battery waste into battery materials, has said it is poised to further strengthen its global patent portfolio to protect its innovative technology. The company said it has now filed National Phase Patent Applications (NPPA) for Europe, South Korea, Canada, India, Australia, Japan, and China - covering the second invention contained in its 'RecycLiCo' battery recycling process. "I'm proud of the excellent patent portfolio that we have built for efficient lithium-ion battery recycling and, in addition, a significant underlying value of American Manganese," Larry Reaugh, the CEO of American Manganese told investors in a statement.
KetamineOne Capital has revealed that its wholly-owned contract research organization, KGK Science Inc., has successfully helped its client, Hofseth Biocare ASA (HBC), to receive New Dietary Ingredient (NDI) status from the US Food and Drug Administration (FDA) for its patented CalGo and OmeGo branded products. Hofseth Biocare develops and markets unique marine-derived calcium, protein, collagen, and lipid nutritional supplements. The company pointed out that the FDA’s NDI notification process is the only pre-market gate for demonstrating quality as well as safety for both ingredients and manufacturing processes. If the ingredient is an NDI or it has been processed in a novel way, an NDI notification is required for the US market by federal law.
Great Atlantic Resources Corp (TSX-V:GR) has revealed promising analytical results from its Golden Promise project in Newfoundland showing that it has intersected high-grade quartz veins with visible gold. Assay results from the company’s 2021 diamond drilling program included 75.5 grams per ton (g/t) gold over 0.35 meters and 20.1 g/t gold over 0.50 meters. The results come from the Jaclyn Main Zone, where eight holes were drilled during the summer in a bid to further define the zone ahead of an updated resource estimate.
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) said it has decided to expand research with Bucillamine as a potential treatment for the coronavirus Omicron variant. It is an oral drug shown to have promising anti-viral and anti-inflammatory capabilities and is being evaluated in a current Phase 3 clinical study for coronavirus (COVID-19). Revive said exploring Bucillamine’s therapeutic potential for the Omicron variant is supported in a recently published research study from the University of California, San Francisco (UCSF), which revealed that potent thiol drugs like Bucillamine inhibit SARS-CoV-2 infection in vitro, specifically the Delta variant.
LexaGene Holdings Inc has announced two purchase orders for its MiQLab Systems from Kuma Veterinary Clinic and the Emergency Veterinary Services of Roanoke. The Beverly, Massachusetts-based molecular diagnostics company noted that the sales were closed with private hospitals. “Veterinarians are learning more about our system and recognizing how wrong it is to have to wait days to weeks for a reference lab to provide infectious disease results that can impact the well-being of their patients,” founder and CEO Dr Jack Regan said in a statement. “Our MiQLab System provides them a solution to this problem, as it delivers high-quality results at the point of need in just ~2 hours. This time savings empowers them to make evidence-based decisions to improve the quality of the care they provide.”
Harbor Custom Development Inc announced that it has acquired Grandis Pond — a 438-acre master-planned community in Blaine — on the Washington-Canadian border for $14 million. The Gig Harbor, Washington-based company said that Grandis Pond is the largest project the company has contracted for purchase to date and will nearly double its current inventory. Harbor told its investors that a mix of residential housing with up to 997 single and multi-family housing units and approximately 48,000 square feet of neighborhood commercial space will be added with the new acquisition. The project is located 33 miles from downtown Vancouver, British Columbia, a city that has a metro market population of nearly three million.
Psyence Group Inc (CSE:PSYG) has said it is commencing a non-brokered private placement offering of up to C$2 million of unsecured convertible promissory notes. The notes are convertible at the option of the holder at any time and will be automatically converted upon the occurrence of certain events at a 20% discount to the market price of the company’s common shares at the time of conversion, subject to a minimum conversion price of $0.25 and a maximum conversion price of $0.40. The notes mature 24 months from their date of issuance and bear interest at a rate of 8% per annum.
Sigma Lithium Corporation said it has filed a final short form base shelf prospectus with the securities regulatory authorities in each of the provinces and territories of Canada, other than the province of Quebec, and a corresponding shelf registration statement on Form F-10 with the United States Securities and Exchange Commission (SEC) under the US/Canada Multijurisdictional Disclosure System. "The base shelf prospectus provides Sigma with the financial flexibility to access capital markets in the next 25 months, as it advances its Grota do Cirilo Project towards production in 2022 and pursues growth opportunities resulting from the tremendous momentum experienced by the lithium industry," said Ana Cabral-Gardner, co-CEO of Sigma. Under the prospectus and corresponding registration statement, Sigma may issue common shares, debt securities, subscription receipts or warrants, in amounts, at prices, and on terms to be determined based on market conditions at the time of sale and set forth in an accompanying prospectus supplement, for an aggregate offering amount of up to US$250 million during the 25-month period that the Prospectus remains effective. There is no certainty that any securities will be offered or sold under the prospectus within the 25-month period.
Esports Entertainment Group Inc has announced that holders of record of the company's 10.0% Series A Cumulative Redeemable Convertible Preferred Stock as of the close of business on December 15, 2021, will receive a cash dividend equal to $0.12 per Series A Preferred Stock share. The cash dividend will be paid on December 31, 2021.
Virtual Investor Conferences, the leading proprietary investor conference series, has announced the agenda for the upcoming Metals & Mining Investor Conference on December 8 and December 9, 2021. Individual investors, institutional investors, advisors, and analysts are invited to listen to the executive management of metals and mining companies discuss their property positions, development schedules, market opportunity, and investment highlights. There is no cost to log-in, attend live presentations or ask questions, and investors can register now via the following link: https://bit.ly/3lv9C6y. "With 28 OTCQX and OTCQB companies presenting, we are excited to host our upcoming two-day Metals & Mining Virtual Investor Conference," said Jason Paltrowitz, executive vice president of Corporate Services at OTC Markets Group. "Our markets are tailored to meet the needs of today's resource companies as they look to engage a broader investor base and we are proud to see them leverage the VIC platform to support their outreach." A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. To view a complete calendar of Virtual Investor Conferences, investors can visit www.virtualinvestorconferences.com.
TPCO Holding Corp - The Parent Company (OTCQX:GRAMF, NEO:GRAMU) - has announced that Troy Datcher, its chief executive officer will participate in two upcoming conferences. At the National Black Caucus of State Legislators (NBCSL) 45th Annual Legislative Conference, Datcher is scheduled to participate in the US Cannabis Council (USCC) panel on December 3, 2021, at 9.00am ET. For more information about the NBCSL 45th Annual Legislative Conference investors can click on the following link: https://www.nbcsl-alc.org/event/d8150420-57b8-442a-9a21-e99abe467d57/summary. At the National Cannabis Industry Association's (NCIA) Business Summit & Expo, Datcher is scheduled to participate as a keynote speaker on December 16, 2021, at 10.15am PT. For more information about the NCIA Business Summit & Expo investors can click on the following link: https://cannabisbusinesssummit.com/
MAS Gold Corp (TSX-V:MAS, OTCQB:MSGCF) said the TSX Venture Exchange has accepted the company's warrant incentive program, designed to encourage the exercise of up to 50,414,299 existing warrants of the company, as described in the company's news release dated August 17, 2021. The early exercise period commenced on August 17, 2021, and expired on September 16, 2021. In connection with the warrant incentive program, a total of 23,517,353 warrants were exercised, providing gross proceeds of $2,565,199.60 to the company and resulting in the company issuing 23,517,353 common shares and 11,758,672 incentive warrants. All warrants that were not exercised under the warrant incentive program continue to entitle the holder to acquire common share as per the original terms of the warrants.
Western Magnesium Corporation has announced that Odyssey Trust Company has replaced Computershare Trust Company of Canada as the registrar and transfer agent of the company's common shares. Shareholders do not need to take any action with respect to the change in transfer agent and registrar.
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that its CEO Dr Ahmad Doroudian will be participating in the H.C. Wainwright 2nd Annual Psychedelics Conference which will be held virtually on Monday, December 6, 2021. The theme of the conference is 'Positioning for the Psychedelic Comeback in Mental Healthcare and Beyond' and the event will assemble all the key thought leaders and companies in the space to discuss this paradigm shift. Dr Doroudian’s presentation will be available starting Monday, December 6 at 7.00am EST. Conference registration and further information can be found at https://hcwevents.com/psychedelics/
Lucky Minerals (TSX-V:LKY, OTC:LKMNF) Inc has announced that it will be participating in Renmark Financial Communications Inc.'s live Virtual Non-Deal Roadshow Series to discuss the latest investor presentation on Monday, December 6, 2021, at 12.00pm CST and Wednesday, December 8, 2021, at 1.00pm PST. The presentation will feature Lucky's president and chief executive officer, François Perron. Topics to be covered will include the latest investor presentation followed by a live Q&A. Investors interested in participating in the events can register using the following links: For Monday, December 6, 2021, in Chicago, Illinois https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-tsx-v-lky-2021-12-06-120000; for Wednesday, December 8, 2021, in Seattle, Washington https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-tsx-v-lky-2021-12-08-130000. Registration for the live event may be limited but access to the replay after the event will be on the company's website.
FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc has announced that Anthony Durkacz, its interim CEO will present at the H.C. Wainwright 2nd Annual Virtual Psychedelics Conference to be held on December 6, 2021. Durkacz’s presentation will be available on-demand for conference attendees starting at 7.00am ET and accessible to view on the investor relations section of FSD’s website at https://ir.fsdpharma.com/news-events/events-presentations. In addition, members of FSD Pharma (CSE:HUGE, NASDAQ:HUGE)’s management team will be available for one-on-one investor meetings during the conference. For more information about the conference, or to schedule a one-on-one meeting with FSD's management team, investors can contact KCSA Strategic Communications at fsdpharma@kcsa.com.
OTC Markets Group Inc, the operator of financial markets for over 11,000 US and global securities, has announced that Envirotech Vehicles Inc, a provider of new purpose-built zero-emission electric vehicles, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTCQB Venture Market. The OTCQX Market provides investors with a premium US public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. "We are excited to begin trading on the OTCQX an upgrade that we believe will expand our visibility to a larger investor audience," commented Phillip Oldridge, CEO of Envirotech Vehicles. "We are seeing tremendous momentum in our business related to growing market recognition of our best-in-class electric trucks and vans and we are benefitting from favorable legislation like the American Jobs Plan and the recently passed infrastructure bill, both of which promote the transition to EVs and incentivize businesses to make the switch. We believe we are well-positioned to drive continued growth and enhanced shareholder value and anticipate that our presence on the OTCQX will enhance our efforts to reach the broader investor community."